The development of drugs to treat some of the world’s most deadly viruses is a primary area of focus by the pharmaceutical community during the last 20 years. There are dozens of antiviral drugs currently approved for use and many times more in development. The ability to easily and quickly follow the impact of a given therapy on viral concentration provides significant advantages over traditional approaches that slow down the pace of research by days or weeks. To learn more, email us at firstname.lastname@example.org.
White Papers & Case Studies
“The Virus Counter has a short assessment time, minimal sample preparation, is easy to use, is a relatively inexpensive platform and assesses the quantity and quality of viral materials.”
—Sanofi Pasteur VaxDesign